LEGIONELLA - World Health Organization
LEGIONELLA - World Health Organization
LEGIONELLA - World Health Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• validation of the effectiveness of control measures<br />
• verification of the effectiveness of decontamination.<br />
If requirements for testing are included in regulations, it is important to define the purpose<br />
of testing and how results will be treated.<br />
10.3 Scope of regulations<br />
Regulations for control of Legionella should be framed within a preventive risk management<br />
approach that is consistent with the approach outlined in WSPs and the Framework for Safe<br />
Drinking-water (WHO, 2004). Preventive risk management is based on the premise that it is<br />
far better to prevent hazardous situations occurring than to wait until they occur and then<br />
take remedial action.<br />
For operational monitoring, risk management relies on measuring parameters that show whether<br />
systems are working properly, rather than relying on end-point testing, which often only<br />
shows whether a system worked at some earlier time.<br />
Risk management strategies for Legionella should incorporate a multiple barrier approach aimed<br />
at controlling the growth, survival and dissemination of the bacteria. Multiple barriers have<br />
long been used to deal with waterborne organisms. Although all barriers should preferably<br />
remain functional at all times, one advantage of the approach is that if one preventive measure<br />
fails, others may maintain adequate protection.<br />
Specific matters that should be covered by regulations include:<br />
• managerial responsibilities and reporting requirements<br />
• system assessment of buildings and devices that are potential sources of Legionella (e.g. cooling<br />
towers, water distribution systems, spa pools, humidifiers, ice machines); this assessment<br />
should consider the susceptibility of those who may be exposed (e.g. transplant and cancer<br />
patients) and those who are immunocompromised or receiving immunosuppressive treatment<br />
• control measures to prevent the growth, survival and dissemination of Legionella<br />
• operational monitoring procedures to ensure that control measures remain functional<br />
whenever devices are in use<br />
• verification procedures to ensure that WSPs are operating effectively<br />
• mechanisms for surveillance and audit of risk management plans.<br />
Regulations could also include requirements relating to notification of disease and responses<br />
to outbreaks of disease.<br />
<strong>LEGIONELLA</strong> AND THE PREVENTION OF LEGIONELLOSIS